Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
This group of lesions can further be divided into: (1) predominantly epidermal lesions ( Table 92.1 ; Figs 92.1–92.5 ); and (2) dermal melanocytoses ( Table 92.2 ; Figs 92.6 and 92.7 ).
Lesion | Major clinical features |
---|---|
Ephelid (freckle) |
|
Lentigo simplex and mucosal melanotic lesions |
|
|
|
|
|
|
|
Solar lentigo (lentigo senilis, “liver spot”) ( Fig. 92.3 ) |
|
Café-au-lait macule (CALM) ( Fig. 92.4 ) |
|
Becker melanosis (nevus) ( Fig. 92.5 ; see Fig. 57.3 and Table 57.1 ) |
|
Lesion | Major clinical features |
---|---|
Congenital dermal melanocytosis (Mongolian spots) ( Fig. 92.6 ) |
|
Nevus of Ota ∗ , ∗∗ (oculodermal melanocytosis, nevus fuscocaeruleus ophthalmo-maxillaris) ( Fig. 92.7 ) |
|
Nevus of Ito ∗ (nevus fuscocaeruleus acromiodeltoideus) |
|
Nevus of Ota-like macules ∗∗ (acquired dermal melanocytosis, acquired bilateral nevus of Ota-like macules, Hori’s nevus) |
|
∗ DDx for nevus of Ota or Ito: patch or plaque blue nevus, ecchymosis, venous malformation; for nevus of Ito: extra-sacral Mongolian spot.
∗∗ Rx (if desired): pulsed Q-switched lasers (e.g. Q-switched ruby, alexandrite, or Nd:YAG lasers) beneficial but often requires multiple sessions.
In the predominantly epidermal lesions, the tan to brown color can result from a variety of mechanisms – e.g. increased melanocyte activity (melanogenesis), increased melanin content in keratinocytes, and a mild increase in the number of melanocytes.
In dermal melanocytoses, the skin is blue to blue-gray in color (ceruloderma) due to the presence of melanin-producing melanocytes in the mid to lower dermis and the resultant Tyndall phenomenon (the preferential scattering of shorter wavelengths of light by the dermal melanin).
Benign proliferations of a type of melanocyte called a “nevus cell”.
Nevus cells differ from “ordinary” melanocytes, which typically reside as single units in the basal layer of the epidermis, in that they: (1) usually cluster as nests in the lower epidermis and/or dermis; and (2) do not have dendritic processes (except when found in a blue nevus).
Both “ordinary” melanocytes and nevus cells can produce melanin.
Acquired melanocytic nevi can be categorized as common (banal) or atypical (dysplastic), and they are further named based on the histopathologic location of the collections of nevus cells ( Fig. 92.8 ):
Junctional melanocytic nevus : dermal–epidermal junction
Compound melanocytic nevus: dermal–epidermal junction plus dermis
Intradermal melanocytic nevus: dermis
Variants include halo, blue, Spitz, and “special site” nevi ( Figs 92.9A–F and 92.10 ).
Risk factors for developing acquired melanocytic nevi: (1) a family history of numerous nevi; (2) a greater degree of sun exposure during childhood, especially intermittent and intense; and (3) lightly pigmented skin (individuals with phototype II have the greatest number of nevi).
The vast majority of acquired melanocytic nevi remain as benign neoplasms throughout one’s life and do not require treatment.
Having numerous melanocytic nevi (>50–100) or multiple atypical nevi are phenotypic markers for an entire skin surface at risk for developing cutaneous melanoma; such persons should have lifelong surveillance with periodic total body skin examinations (beginning around puberty) and counseling regarding home self-skin examinations and sun protective measures.
Cutaneous melanoma may arise within a pre-existing nevus, but more than half of cutaneous melanomas arise de novo – i.e. in previously normal-appearing skin.
Most patients with numerous nevi and atypical nevi will have a prominent morphologic type of nevus (“signature nevus”); by recognizing signature nevi, the “ugly duckling” can be identified and closely examined.
Persons with more darkly pigmented skin will typically have darker colored nevi.
Rx: it is not necessary to remove clinically atypical nevi prophylactically in order to confirm the presence of histopathological atypia; biopsies of nevi are indicated primarily when a severely atypical nevus or cutaneous melanoma is in the DDx ( Table 92.4 ); if banal nevi become irritated (e.g. by clothing or jewelry), shave removal can be done.
When cutaneous melanoma is in the DDx , complete removal of the nevus is recommended as well as submission to a dermatopathologist; removal can be accomplished by several methods (see Fig. 1.6 ); providing additional information (e.g. eccentric hyperpigmented area) is also helpful.
Benign lesions with varied clinical appearance, but typically ≤6 mm in diameter, symmetric, well-circumscribed, evenly pigmented, and round or oval in shape; perifollicular hypopigmentation or stippled pigmentation is often present upon closer inspection.
Distribution favors intermittently sun-exposed areas of the trunk and extremities and, less frequently, acral sites (palms, soles, nail matrix); in patients who eventually develop many nevi, the scalp may be one of the first sites of involvement.
Classically appear after the first 6 months of life, increase in number during childhood and adolescence, peak by the third decade, and then slowly regress with age.
As nevi “age” over time, they often become more elevated, softer, and less pigmented.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here